News – Page 343
-
ResearchSuperatom mimics for rare earth elements
Clusters of boron-doped metals have identical properties to other rare earth elements
-
Business
BMS invests in gene therapy
Bristol-Myers Squibb makes $100 million deal with biotech uniQure
-
ResearchLawrencium experiment could shake up periodic table
Measurement of first ionisation energy confirms electronic configuration but opens up an important debate
-
ResearchSalty soil set to hamper Bangladesh crop production
Scientists model impact of climate change on agriculture
-
Business
Leak causes explosion at para-xylene plant in China
Twelve injured by explosion and fire caused by a leaking xylene tank at chemical plant
-
ResearchThe Goldilocks of heterogeneous catalysis
Dangling thiols anchor palladium within MOF without poisoning its catalytic activity
-
NewsFuture of GM in Germany hangs in the balance
German science academy speaks out in favour of GM crops as debate begins on whether to ban them
-
ResearchSuper-fast charging aluminium batteries ready to take on lithium
New battery charges in under a minute and still performs perfectly after being recharged thousands of times
-
NewsMetrics failed to predict REF outcomes
Predictions based on numerical measures of research quality were ‘wildly innacurate’, say mathematicians
-
Business
Novartis accused of ‘derailing’ trials for cheap eye disease drug
BMJ says pharma giant is trying to block access to a drug that would save the NHS millions
-
ResearchDNA test colours in BRCA1 gene
Rolling circle amplification aids femtomolar sensitivity for gene linked with breast cancer
-
Business
Horizon to acquire orphan drugs in $1.1bn Hyperion takeover
Horizon will buy Hyperion and add new drugs to its rare disease portfolio
-
Business
Sun Pharma snares Ranbaxy in $4bn deal
Acquisition makes Sun biggest drug firm in India and fifth largest generics producer in the world
-
BusinessEnvironmental research goes private
Exclusive interview with Fera chief Hilary Aldridge as the UK’s Food and Environment Research Agency becomes majority-owned by Capita
-
Business
Dow sells off chlorine assets in $5bn deal
US chemical giant disposes of unwanted operations in tax-free deal
-
Business
Teva buys Auspex Pharmaceuticals for $3.2bn
Generics giant will add late stage Huntingdon’s drug to CNS portfolio
-
ResearchBounce denotes battery health
Physical changes as battery discharges correlated with bounce
-
News
Scientists raise concern over fast-track peer review scheme
Payment scheme for expedited review leads one editor of Scientific Reports to resign
-
NewsUS Chemical Safety Board chairman resigns
Resignation follows accusation of mismangement and exposure of whistleblowers
-
NewsFears UK government scientists could be gagged by new rules
Civil service code changes mean government employees need ministerial permission to speak to the press